Simultaneous Quantification of Baricitinib and Methotrexate in Rat Plasma by LC-MS/MS: Application to a Pharmacokinetic Study

por Veeraraghavan, Sridhar, Thappali, Satheeshmanikandan R. S., Viswanadha, Srikant, Vakkalanka, Swaroop, Rangaswamy, Manivannan
Publicado 2016

Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders

por Routhu, Kasi Viswanath, Veeraraghavan, Sridhar, Merikapudi, Gayatri Swaroop, G, Babu, Viswanadha, Srikant, Vakkalanka, Swaroop
Publicado 2013

Simultaneous Determination of Celecoxib, Erlotinib, and its Metabolite Desmethyl-Erlotinib (OSI-420) in Rat Plasma by Liquid chromatography/Tandem Mass Spectrometry with Positive/N...

por Thappali, Satheeshmanikandan R. S., Varanasi, Kanthikiran, Veeraraghavan, Sridhar, Arla, Rambabu, Chennupati, Sandhya, Rajamanickam, Madheswaran, Vakkalanka, Swaroop, Khagga, Mukkanti
Publicado 2012

Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma

por Gardner, Heather L., Rippy, Sarah B., Bear, Misty D., Cronin, Kim L., Heeb, Heather, Burr, Holly, Cannon, Claire M., Penmetsa, Kumar V., Viswanadha, Srikant, Vakkalanka, Swaroop, London, Cheryl A.
Publicado 2018

Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma

por Huen, Auris, Haverkos, Bradley M., Zain, Jasmine, Radhakrishnan, Ramchandren, Lechowicz, Mary Jo, Devata, Sumana, Korman, Neil J., Pinter-Brown, Lauren, Oki, Yasuhiro, Barde, Prajak J., Nair, Ajit, Routhu, Kasi Viswanath, Viswanadha, Srikant, Vakkalanka, Swaroop, Iyer, Swaminathan P.
Publicado 2020